Lupin recall
WebCONSUMER LEVEL RECALL NOTIFICATION OF METFORMIN. Effective 07/17/2024, Lupin Pharmaceuticals, Inc. is initiating a voluntary recall of all lots of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg, for NDC 68180-336-07, 68180-337-07, 68180-338-01 and 68180-339-09 shipped from Lupin Pharmaceuticals, … WebOct 20, 2024 · The recall affects all of Lupin’s Irbesartan tablets (75 mg, 150 mg, and 300 mg), and Irbesartan and Hydrochlorothiazide tablets (150 mg/12.5 mg and 300 mg/12.5 …
Lupin recall
Did you know?
WebAug 9, 2024 · The Mumbai-based drug maker Lupin is recalling 11,688 bottles of Lisinopril tablets USP, 10 mg, which is used to treat high blood pressure, in the US market, as per the latest Enforcement Report by the US health regulator. Agencies Usually, domestic firms cater to the US and domestic markets from separate facilities. WebLupin We are an innovation-led, global pharmaceutical company DISCOVER LUPIN Through ongoing product development, as well as strategic acquisitions, our specialty …
WebOct 24, 2024 · Lupin had already discontinued in January 2024 the marketing of both irbesartan alone and irbesartan plus HCTZ. Nevertheless, such tablets are still out there. … WebOct 16, 2024 · Lupin’s FDA-posted recall notice said “ certain tested [active pharmaceutical ingredient] batches (but not finished product batches) were above the specification limit for the impurity,...
WebDec 21, 2024 · Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential presence of N-Nitroso-Quinapril Impurity News … WebMay 15, 2024 · The Baltimore-based Lupin Pharmaceuticals Inc, a unit of Mumbai-based Lupin, initiated the nationwide Class II recall on March 31 this year. The affected lot has been manufactured at Lupin's Pithampur-based plant in Madhya Pradesh. The lot has been distributed in the US by Baltimore-based Lupin Pharmaceuticals Inc, the report stated.
WebLisinopril Recall. In 2016, Lupin Pharmaceuticals Inc recalled 30mg and 40mg bottles of Lisinopril tablets as a result of contamination during manufacturing. The previous year, Wockhardt recalled its 5mg and 20mg tablets for the same reason. As of August 2016, the FDA has banned three of their manufacturing facilities.
WebOct 14, 2024 · The company in a statement said that Lupin Pharmaceuticals Inc is voluntarily recalling lrbesartan tablets and lrbesartan and Hydrochlorothiazide tablets to … scott burdick northstarWebDec 28, 2024 · The recall affects all Lupin Pharmaceuticals Inc.’s Quinapril tablets that are sold in 20 mg and 40 mg packs. The bottles carry expiration dates ranging from December 2024 to March 2024, and ... scott burdick deputy directorWebOct 20, 2024 · The Food and Drug Administration said late last week that Lupin is voluntarily recalling certain dosages of irbesartan tablets and irbesartan and … scott burch physical therapyWebDec 21, 2024 · Baltimore, Maryland, December 21, 2024: Lupin Pharmaceuticals Inc. is voluntarily recalling four (4) lots of Quinapril Tablets to the patient (consumer/user) level due to the presence of a... scott burch police officerWebstrongly encourages pharmacies to immediately review their quality assurance and recall policies and procedures to determine if any corrective action is required. Lupin Pharmaceuticals Inc. is initiating a market withdrawal of lot . L001323, Expiry July 2024, of . Levothyroxine Sodium Tablets USP, 137mcg (0.137mg) to the . retail . level. scott burdick softraxWebDec 22, 2024 · December 22, 2024. Lupin Pharmaceuticals has recalled four lots of the blood pressure medication Quinapril after detection of the cancer-causing impurity nitrosamine above the acceptable daily intake level set by the Food and Drug Administration (FDA). Elevated levels of the nitrosamine impurity N-Nitroso-Quinapril were detected in … scott burford investment bankingWebOct 14, 2024 · The company in a statement said that Lupin Pharmaceuticals Inc is voluntarily recalling lrbesartan tablets and lrbesartan and Hydrochlorothiazide tablets to the consumer level. The tablets have been recalled due to potential presence of N-nitrosoirbesartan impurity, a substance that could cause cancer. scott burdick watercolour